Aarti Pharmalabs Board Approves Financials, Management Changes, and Capex

Aarti Pharmalabs Ltd's Board of Directors, in a meeting held on August 7, 2026, approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026, along with the Limited Review Report. Key management changes were approved, including Shri. Rashesh C. Gogri's transition from Non-Executive Director to Managing Director and Smt. Hetal Gogri Gala's move from Managing Director to Executive Director, both effective October 1, 2026, subject to shareholder approval. The board also sanctioned a capacity addition for an Intermediate Block with an estimated capital expenditure of ₹149 Crores. Furthermore, committees including the Audit Committee, CSR Committee, and Stakeholders Relationship Committee were reconstituted.